{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:08:01Z","timestamp":1786122481808,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Objective: The prevalence and clinical impact of iron deficiency (ID) in patients with heart failure (HF) in Oman remain insufficiently characterized. This study aimed to evaluate the prevalence of ID and its association with clinical outcomes, as well as to assess the impact of iron supplementation on hospitalization and mortality among HF patients. Methods: A retrospective observational cohort study included adult patients (\u226518 years) with HF who had \u22652 iron profiles; patients with end-stage renal disease were excluded. ID was defined using American Heart Association (AHA) and European Society of Cardiology (ESC) criteria. Results: Of 2246 patients screened, 211 met inclusion criteria (57.8% female; mean age 70 \u00b1 12.7 years). ID prevalence was 68.3% (AHA) and 71.1% (ESC), with ESC criteria detecting more biochemical deficiencies. ID was associated with higher all-cause and HF-related readmissions (p &lt; 0.01), longer length of stay (p = 0.045), and more atrial fibrillation (AF) (p &lt; 0.01). All-cause mortality was similar, although the composite of mortality and readmission was slightly higher with ID (p = 0.052). Iron supplementation significantly increased ferritin (+32 ng\/mL) and transferrin saturation (+2.8%) (p &lt; 0.01) and was linked to fewer strokes (p = 0.049), with no major differences in other outcomes. Conclusions: The study found that ID was highly prevalent; however, systematic screening was not routinely practiced, which largely led to delayed initiation of appropriate management. Routine ESC-guided ID screening and management are recommended. However, given the retrospective, non-randomized study design, these findings should not be interpreted as evidence of a causal treatment effect and are likely influenced by confounding by indication. Prospective randomized studies are needed to confirm these observations.<\/jats:p>","DOI":"10.3390\/jcm15166142","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T10:12:01Z","timestamp":1786097521000},"page":"6142","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Iron Supplementation on Clinical Outcomes in Iron-Deficient Heart Failure Patients: A Retrospective Cohort Study in Oman"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4251-5358","authenticated-orcid":false,"given":"Dania","family":"Abunaser","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat 123, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5309-7780","authenticated-orcid":false,"given":"Juhaina S.","family":"Al Maqbali","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-6095","authenticated-orcid":false,"given":"Salim","family":"Al Busaidi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9253-3562","authenticated-orcid":false,"given":"Yousra","family":"Nomier","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat 123, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8887-2537","authenticated-orcid":false,"given":"Yousuf","family":"Al Suleimani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat 123, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global Public Health Burden of Heart Failure: An Updated Review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cardfail.2023.03.025","article-title":"Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America","volume":"29","author":"Beavers","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: A multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric Carboxymaltose in Heart Failure with Iron Deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_7","first-page":"895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of Oral Iron Repletion on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/ejhf.3237","article-title":"Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure","volume":"26","author":"Packer","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e001012","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: A systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/ehf2.14849","article-title":"Iron deficiency in new onset heart failure: Association with clinical factors and quality of life","volume":"11","author":"Cabrera","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbagen.2011.10.013","article-title":"Regulation of iron transport and the role of transferrin","volume":"1820","author":"Gkouvatsos","year":"2012","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e01","DOI":"10.15420\/japsc.2023.39","article-title":"Prevalence and Spectrum of Iron Deficiency in Heart Failure Patients in a Tertiary Cardiac Centre in Nepal","volume":"3","author":"Kharel","year":"2024","journal-title":"J. Asian Pac. Soc. Cardiol."},{"key":"ref_15","first-page":"27167","article-title":"Anemia and Heart Failure: A Narrative Review","volume":"14","author":"Siddiqui","year":"2022","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.18295\/squmj.2020.20.02.005","article-title":"National Prevalence of Micronutrient Deficiencies, Anaemia, Genetic Blood Disorders and over- and Undernutrition in Omani Women of Reproductive Age and Preschool Children","volume":"20","author":"Petry","year":"2020","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.26719\/2001.7.6.1004","article-title":"A community-based study of common hereditary blood disorders in Oman","volume":"7","author":"Suleiman","year":"2001","journal-title":"East. Mediterr. Health J."},{"key":"ref_18","unstructured":"Oman Hereditary Blood Disorder Association (2026, August 05). Oman Hereditary Blood Disorder. Available online: https:\/\/omancares.org\/en\/areas-of-work\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: An international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.2879","article-title":"Iron deficiency in heart failure: Screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm creatinine Measurements collaborative project","volume":"25","author":"Lindberg","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jchf.2020.03.008","article-title":"Impaired Exercise Tolerance in Heart Failure with Preserved Ejection Fraction","volume":"8","author":"Nayor","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sindone, A., Doehner, W., Manito, N., McDonagh, T., Cohen-Solal, A., Damy, T., N\u00fa\u00f1ez, J., Pfister, O., Van Der Meer, P., and Comin-Colet, J. (2022). Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11112976"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/ehf2.13265","article-title":"Iron deficiency in heart failure","volume":"8","author":"Loncar","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Vilella, R., Donoso Trenado, V., Jover Pastor, P., S\u00e1nchez-L\u00e1zaro, I., Mart\u00ednez Dolz, L., and Almenar Bonet, L. (2022). Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study. Life, 12.","DOI":"10.3390\/life12111828"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"106345","DOI":"10.1016\/j.phrs.2022.106345","article-title":"Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials","volume":"182","author":"Mei","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1097\/MS9.0000000000002907","article-title":"Anemia and cerebrovascular disease: Pathophysiological insights and clinical implications","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hanna-Rivero, N., Tu, S.J., Elliott, A.D., Pitman, B.M., Gallagher, C., Lau, D.H., Sanders, P., and Wong, C.X. (2022). Anemia and iron deficiency in patients with atrial fibrillation. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02633-6"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/clc.23764","article-title":"Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study","volume":"45","author":"Zhang","year":"2022","journal-title":"Clin. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: An updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_30","first-page":"e202410","article-title":"Benefits of intravenous iron supplementation in heart failure","volume":"2024","author":"Kotit","year":"2024","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ehf2.12400","article-title":"Differences between intravenous iron products: Focus on treatment of iron deficiency in chronic heart failure patients","volume":"6","author":"Borchard","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3892\/etm.2021.10703","article-title":"Association between obesity and iron deficiency (Review)","volume":"22","author":"Alshwaiyat","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The Association of Obesity and Cardiometabolic Traits with Incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6142\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T10:21:23Z","timestamp":1786098083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":33,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166142"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166142","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}